Prophylaxis and on-demand treatment respectively in patients with haemophilia A with or without FVIII inhibitors.
Conditions
Interventions
None listed
Sponsors
Novo Nordisk A/S
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Countries
Germany
Outcome results
None listed